3 research outputs found

    ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection

    Get PDF
    Upon viral infection, the production of type I interferon (IFN) and the subsequent upregulation of IFN stimulated genes (ISGs) generate an antiviral state with an important role in the activation of innate and adaptive host immune responses. The ubiquitin-like protein (UBL) ISG15 is a critical IFN-induced antiviral molecule that protects against several viral infections, but the mechanism by which ISG15 exerts its antiviral function is not completely understood. Here, we report that ISG15 plays an important role in the regulation of macrophage responses. ISG152/2 macrophages display reduced activation, phagocytic capacity and programmed cell death activation in response to vaccinia virus (VACV) infection. Moreover, peritoneal macrophages from mice lacking ISG15 are neither able to phagocyte infected cells nor to block viral infection in co-culture experiments with VACV-infected murine embryonic fibroblast (MEFs). This phenotype is independent of cytokine production and secretion, but clearly correlates with impaired activation of the protein kinase AKT in ISG15 knock-out (KO) macrophages. Altogether, these results indicate an essential role of ISG15 in the cellular immune antiviral response and point out that a better understanding of the antiviral responses triggered by ISG15 may lead to the development of therapies against important human pathogens

    Meta- and Orthogonal Integration of Influenza ‘OMICs’ Data Reveals UBR4 as a Critical Regulator of M2 Ion Channel Membrane Trafficking

    No full text
    Systems-level analyses of the molecular interfaces between influenza A and its human host have provided considerable new insights into cellular circuits and processes that govern viral infection. However, apparent discordant results from various approaches, including RNAi screens and proteomics studies, have hampered leveraging of these findings to advance mechanistic and therapeutic knowledge. To collectively reconcile these datasets, we have performed a meta-analysis of previously unpublished primary datasets sets from 4 siRNA screens, along with results from an additional 4 RNAi screens, to rank prioritize host and restriction factors that were found to impact viral replication in multiple datasets. This approach enabled us to identify nearly 200 published factors, as well as the 57 previously unreported host proteins, with activities supported by multiple datasets, and indicate ~50% overlap of published genes when observed at the level of cellular pathways or biochemical complexes. Further integration of these data with published and experimentally generated protein interaction data revealed the landscape of biochemical interactions between 264 host proteins found to be essential for influenza A replication and 11 virally encoded proteins. Notably, we find that the putative E3 ligase UBR4 physically associates with the virally encoded M2 protein to direct it’s trafficking to the cellular membrane. Inhibition of UBR4 results in relocalization of M2 with the autophagosomal marker ARHI and also its degradation, resulting in a severe attenuation of late phase influenza A replication. The requirement for this host protein was found to be restricted to human, but not avian, strains of the virus, suggesting that adaptations that enable the appropriation of mammalian UBR4 may be critical to zoonotic transmission and/or pathogenesis. Taken together, the integrative analysis of influenza OMICs datasets illuminate a viral-host network of high confidence human proteins that are essential for influenza A replication, and furthermore uncovers a role for UBR4 in the trafficking of the virally-encoded M2 ion channel to the cell membrane to enable viral egress
    corecore